RE:News releasesLemoyne wrote: How in the hell can you generate shareholder value with these news (posted over the past year and that were not related to earnings or meetings).
- MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
- MediPharm Labs Announces $2.1M Debt Repayment. Company Now Materially Debt Free with Over $13M in Cash
- MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
- MediPharm Labs Provides Update on German Cannabis Legalization
- MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
1. Only 5 NRs !?!? Of which only one has a potential growth component (Remidose), and an insignificant one at that.
They freakin talked about shareholder value at their march cc and have done nothing to change it.
Financials show improvement, but heck, you gotta have visibility for people to notice those earnings. I wouldn't be surprised next earnings have no analyst showing up...
I mean, if they announce next earnings tonight, after markets close, before a long week end, what are they up to?
Welcome friend. To pile on, there have been no updates whatsoever on the catalysts they have been tracking for years. So here we are at 6.5c, again, with essentially zero interest and credibility in the market because of the cone of silence. So for all of the praise (deservedly so) that they have earned for putting the business on sure footing, the actual growth and strategic initiatives have long been wanting. I very much hope that was not the reason why Strachan got moved to the Board. If so, recovery for years of potential neglect won't come quickly or easy given the might of others.